List view / Grid view


Phico Therapeutics receives Translation Award to advance its SASPject™ PT4 aimed at Escherichia coli and Klebsiella pneumoniae towards clinical trials

9 March 2015 | By Phico Therapeutics

Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a £2.25M Translation Award by the Wellcome Trust to develop its SASPject™ PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumoniae...

Manipulating cells’ shapes could treat breast cancer

4 March 2015 | By The Institute of Cancer Research

Changing the shape of breast cancer cells could make the disease more sensitive to treatments – even driving the body’s own inflammatory response against a tumour – a new study shows...